AVTX · Forms 3, 4, 5
Insider trades at Avalo Therapeutics, Inc.
3 insiders sold $2M of Avalo Therapeutics, Inc. stock on the open market in the last 90 days.
Every Form 3, 4 and 5 filed for Avalo Therapeutics, Inc. (AVTX) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Rita Jain | Director | Options or other derivatives | Form 4 | ||||
| Kevin Robert Lind | Director | Options or other derivatives | Form 4 | ||||
| Ron M Philip | Director | Options or other derivatives | Form 4 | ||||
| Christopher Ryan Sullivan | Chief Financial Officer | Option exercise | 12,394 | $9.88 | $122K | Form 4 | |
| Christopher Ryan Sullivan | Chief Financial Officer | Sell | 12,394 | $16.33 | $202K | Form 4 | |
| Christopher Ryan Sullivan | Chief Financial Officer | Option exercise | 10,185 | $8.04 | $82K | Form 4 | |
| Christopher Ryan Sullivan | Chief Financial Officer | Sell | 10,185 | $17.62 | $179K | Form 4 | |
| Mittie Doyle | Chief Medical Officer | Option exercise | 679 | $8.04 | $5K | Form 4 | |
| Mittie Doyle | Chief Medical Officer | Sell | 679 | $20.00 | $14K | Form 4 | |
| Christopher Ryan Sullivan | Chief Financial Officer | Option exercise | 31,031 | $9.88 | $307K | Form 4 | |
| Christopher Ryan Sullivan | Chief Financial Officer | Sell | 31,031 | $20.05 | $622K | Form 4 | |
| Christopher Ryan Sullivan | Chief Financial Officer | Option exercise | 37,945 | $9.88 | $375K | Form 4 | |
| Christopher Ryan Sullivan | Chief Financial Officer | Option exercise | 2,876 | $9.88 | $28K | Form 4 | |
| Christopher Ryan Sullivan | Chief Financial Officer | Sell | 37,945 | $19.85 | $753K | Form 4 | |
| Christopher Ryan Sullivan | Chief Financial Officer | Sell | 3,749 | $19.94 | $75K | Form 4 | |
| Mittie Doyle | Chief Medical Officer | Option exercise | 1,000 | $12.65 | $13K | Form 4 | |
| Mittie Doyle | Chief Medical Officer | Sell | 1,000 | $20.00 | $20K | Form 4 | |
| Jennifer Riley | Chief Strategy Officer | Sell | 2,655 | $19.59 | $52K | Form 4 | |
| Mittie Doyle | Chief Medical Officer | Option exercise | 679 | $8.04 | $5K | Form 4 | |
| Mittie Doyle | Chief Medical Officer | Sell | 679 | $20.00 | $14K | Form 4 | |
| Mittie Doyle | Chief Medical Officer | Option exercise | 1,000 | $12.65 | $13K | Form 4 | |
| Mittie Doyle | Chief Medical Officer | Sell | 1,000 | $20.00 | $20K | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.